AccessPak for HIV PEP Expanded with Kaletra and Tafenoquine (Malaria Prevention)
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Tafenoquine (Malaria Prevention) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Tafenoquine (Prevention of Malaria Relapse)
- AccessPak for HIV PEP Expanded with Kaletra-Tafenoquine Succinate (Arakoda)
- AccessPak for HIV PEP Expanded with Kaletra-Tafenoquine Succinate (Krintafel)
- AccessPak for HIV PEP Expanded with Kaletra-Tafinlar
- AccessPak for HIV PEP Expanded with Kaletra-Tafluprost
- AccessPak for HIV PEP Expanded with Kaletra-Tafluprost ophthalmic
- Tafenoquine (Malaria Prevention)-AccessPak for HIV PEP Expanded with Viracept
- Tafenoquine (Malaria Prevention)-Accolate
- Tafenoquine (Malaria Prevention)-Accretropin
- Tafenoquine (Malaria Prevention)-Accucaine
- Tafenoquine (Malaria Prevention)-AccuHist Drops
- Tafenoquine (Malaria Prevention)-AccuHist PDX Drops